Optical spectroscopy pathlength measurement system
View Patent ↗A physiological monitor utilizes rotation measurements to estimate mean photon pathlengths through tissue. These pathlength estimates, along with corresponding optical spectroscopy measurements allow the noninvasive monitoring of blood constituent concentrations. The technique is particularly applicable to noninvasive blood glucose measurements. The physiological monitor has a polarized light source for illuminating tissue and a magnetic field generator which creates a magnetic field within the tissue during illumination. The magnetic field imparts a rotation in the plane of polarization of the incident light beam as it propagates through the tissue and emerges as a transmitted light beam. A polarimeter is used to measure the rotation of the transmitted light. A signal processor then computes an estimate of the mean pathlength from the polarimeter output. The polarized light source has a multiple wavelength optical emitter and, in conjunction with the polarimeter detector, also functions as a spectrometer. The signal processor combines spectroscopic measurements at various wavelengths with corresponding mean pathlength estimates to compute blood constituent concentrations.
1. An optical pathlength measurement system for determining a pathlength of a light source passing through a tissue sample comprising:
an optical emitter for emitting light of one or more wavelengths;
a first filter for filtering the light emitted from the optical emitter;
a magnetic field generator for optically rotating the light as it passes through a tissue sample;
a second filter for filtering the light after it passes through the tissue sample;
a detector for detecting the light after it passes through the second filter; and
a processor for determining and outputting a pathlength of the light emitted from the optical emitter based on the optical rotation of the light for use in determining a physiological characteristic of the tissue sample.
2. The optical pathlength measurement system of claim 1 , wherein the first and second filters comprise first and second polarizers respectively.
3. The optical pathlength measurement system of claim 2 , further comprising a modulator for modulating the light after it passes through the first polarizer.
4. The optical pathlength measurement system of claim 3 , wherein the modulator is driven by a sinusoidal source for phase modulating an electric field of the light.
5. The optical pathlength measurement system of claim 3 , wherein the modulator is a faraday rotator modulator.
6. The optical pathlength measurement system of claim 2 , wherein the first polarizer comprises a polarization axis oriented at a reference angle.
7. The optical pathlength measurement system of claim 6 , wherein the second polarizer comprises a polarization axis oriented orthogonally to the polarization axis of the first polarizer.
8. The optical pathlength measurement system of claim 7 , wherein a polarization axis of the second polarizer is located at an angle of forty-five degrees from the reference angle.
9. The optical pathlength measurement system of claim 6 , wherein the reference angle is zero degrees from the horizontal.
10. The optical pathlength-measurement system of claim 1 , further comprising a photoelastic modulator for modulating the light after is passes through the tissue.
11. A method of determining an optical pathlength of a light after it passes through a tissue sample comprising:
irradiating a beam of light;
applying a first filter to the light;
applying a field configured to optically rotate the light as it passes through a tissue sample;
applying a second filter to the light;
detecting the rotation of the light;
calculating a pathlength based on the rotation of the light.
12. The method of claim 11 , wherein the first and second filters comprise first and second polarizers respectively.
13. The method of claim 11 , further comprising modulating the light before it passes through the tissue sample.
14. The method of claim 13 , wherein modulating the light further comprises phase modulating the light.
15. The method of claim 14 , wherein modulating the light further comprises modulating the light using a sinusoidal source.
16. The method of claim 11 , further comprising modulating the light after it passes through the tissue sample.
17. The method of claim 16 , further comprising photoelastically modulating the light.
18. An optical pathlength measurement system for determining a pathlength of a light source passing through a tissue sample comprising:
means for emitting light of one or more wavelengths;
means for filtering the light emitted from the multiple wavelength optical emitter;
means for optically rotating the light as it passes through a tissue sample;
a second means for filtering the light after it passes through the tissue sample;
means for detecting the light after it passes through the second polarizer; and
means for determining and outputting a pathlength of the light emitted from the multiple wavelength optical emitter based on the optical rotation of the polarized light for use in determining a physiological characteristic of the tissue sample.